Qube Research & Technologies (QRT)’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,919
Closed -$62.9K 3780
2024
Q2
$62.9K Sell
9,919
-10,561
-52% -$81.2K ﹤0.01% 2695
2024
Q1
$190K Buy
20,480
+18,711
+1,058% +$219K ﹤0.01% 3045
2023
Q4
$22.6K Buy
+1,769
New +$18.4K ﹤0.01% 3464
2022
Q3
Sell
-54,651
Closed -$804K 2793
2022
Q2
$804K Buy
+54,651
New +$1.13M 0.01% 1192
2021
Q2
Sell
-14,185
Closed -$649K 2583
2021
Q1
$649K Buy
+14,185
New +$814K 0.01% 1029

Other funds holding LUNG

Qube Research & Technologies (QRT)'s LUNG Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Pulmonx (LUNG) in Q3 2024, closing a stake of 9,919 shares — an estimated $62.9K sold.

Qube Research & Technologies (QRT) first reported a position in LUNG in Q1 2021 and held it in 5 quarters. The position peaked at $804K in Q2 2022. 113 funds tracked by Wall St. Rank hold LUNG as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Pulmonx position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 9,919 Pulmonx shares in Q3 2024, an estimated $62.9K.
  • Qube Research & Technologies (QRT) first reported a position in Pulmonx in Q1 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Pulmonx position peaked at $804K in Q2 2022.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.